bluebird bio Inc.

7.85
0.01 (0.13%)
Jan 23, 2025, 1:21 PM - Market open

bluebird bio Statistics

Share Statistics

bluebird bio has 9.72M shares outstanding. The number of shares has increased by -94.96% in one year.

Shares Outstanding 9.72M
Shares Change (YoY) n/a
Shares Change (QoQ) -94.99%
Owned by Institutions (%) n/a
Shares Floating 9.64M
Failed to Deliver (FTD) Shares 12.30K
FTD / Avg. Volume 2.97%

Short Selling Information

The latest short interest is 47.71M, so 490.69% of the outstanding shares have been sold short.

Short Interest 47.71M
Short % of Shares Out 490.69%
Short % of Float 495.05%
Short Ratio (days to cover) 9.53

Valuation Ratios

The PE ratio is -14.3 and the forward PE ratio is -0.6.

PE Ratio -14.3
Forward PE -0.6
PS Ratio 102.76
Forward PS 0.2
PB Ratio 15.58
P/FCF Ratio -12.42
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

bluebird bio Inc. has an Enterprise Value (EV) of 712.19M.

EV / Earnings -3.36
EV / Sales 24.14
EV / EBITDA -4.26
EV / EBIT -2.92
EV / FCF -2.92

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 1.7.

Current Ratio 1.41
Quick Ratio 1.29
Debt / Equity 1.7
Total Debt / Capitalization 62.94
Cash Flow / Debt -0.71
Interest Coverage -14.94

Financial Efficiency

Return on equity (ROE) is -1.09% and return on capital (ROIC) is -46.51%.

Return on Equity (ROE) -1.09%
Return on Assets (ROA) -0.34%
Return on Capital (ROIC) -46.51%
Revenue Per Employee 78.66K
Profits Per Employee -565.10K
Employee Count 375
Asset Turnover 0.05
Inventory Turnover 1.46

Taxes

Income Tax -126.00K
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -63.13% in the last 52 weeks. The beta is 0.8, so bluebird bio 's price volatility has been higher than the market average.

Beta 0.8
52-Week Price Change -63.13%
50-Day Moving Average 8.11
200-Day Moving Average 14.5
Relative Strength Index (RSI) 45.77
Average Volume (20 Days) 414.02K

Income Statement

In the last 12 months, bluebird bio had revenue of 29.50M and earned -211.91M in profits. Earnings per share was -1.93.

Revenue 29.50M
Gross Profit -4.03M
Operating Income -244.26M
Net Income -211.91M
EBITDA -167.16M
EBIT -244.26M
Earnings Per Share (EPS) -1.93
Full Income Statement

Balance Sheet

The company has 221.75M in cash and 330.33M in debt, giving a net cash position of -108.57M.

Cash & Cash Equivalents 221.75M
Total Debt 330.33M
Net Cash -108.57M
Retained Earnings -4.26B
Total Assets 465.06M
Working Capital -145.22M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -235.05M and capital expenditures -9.06M, giving a free cash flow of -244.10M.

Operating Cash Flow -235.05M
Capital Expenditures -9.06M
Free Cash Flow -244.10M
FCF Per Share -2.22
Full Cash Flow Statement

Margins

Gross margin is -13.66%, with operating and profit margins of -828.09% and -718.42%.

Gross Margin -13.66%
Operating Margin -828.09%
Pretax Margin -718.85%
Profit Margin -718.42%
EBITDA Margin -566.71%
EBIT Margin -828.09%
FCF Margin -827.55%

Dividends & Yields

BLUE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -24.46%
FCF Yield -318.22%
Dividend Details

Analyst Forecast

The average price target for BLUE is $36.8, which is 366.4% higher than the current price. The consensus rating is "Hold".

Price Target $36.8
Price Target Difference 366.4%
Analyst Consensus Hold
Analyst Count 9
Stock Forecasts

Stock Splits

The last stock split was on Dec 13, 2024. It was a backward split with a ratio of 1:20.

Last Split Date Dec 13, 2024
Split Type backward
Split Ratio 1:20

Scores

Altman Z-Score -15.05
Piotroski F-Score 2